Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Tumors, Non-small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01166035
What this trial is testing

Lenalidomide and Cetuximab in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Medical University Innsbruck 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05887492
What this trial is testing

Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors

Who this might be right for
Non Small Cell Lung CancerSolid Tumors, AdultLung Cancer+1 more
Tango Therapeutics, Inc. 126
Early research (Phase 1)UnknownNCT06078800
What this trial is testing

YL-17231 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Shanghai YingLi Pharmaceutical Co. Ltd. 80
Testing effectiveness (Phase 2)Looking for participantsNCT05579366
What this trial is testing

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Who this might be right for
High Grade Epithelial Ovarian CancerHigh Grade Serous Ovarian CancerPrimary Peritoneal Carcinoma+12 more
Genmab 884
Early research (Phase 1)Study completedNCT03849469
What this trial is testing

XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

Who this might be right for
MelanomaCervical CarcinomaPancreatic Carcinoma+20 more
Xencor, Inc. 78
Testing effectiveness (Phase 2)Looking for participantsNCT04198766
What this trial is testing

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Who this might be right for
Solid TumorNon-Small Cell Lung CancerHead and Neck Cancer+5 more
Inhibrx Biosciences, Inc 340
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439253
What this trial is testing

Testing Crizotinib as a Potential Targeted Treatment in Cancers With ROS1 Genetic Changes (MATCH-Subprotocol G)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 4
Early research (Phase 1)Looking for participantsNCT07094113
What this trial is testing

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

Who this might be right for
KRAS Altered Advanced or Metastatic Solid Tumors
Amgen 434
Testing effectiveness (Phase 2)Study completedNCT02460224
What this trial is testing

Safety and Efficacy of LAG525 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.

Who this might be right for
Advanced Solid Tumors
Novartis Pharmaceuticals 490
Early research (Phase 1)UnknownNCT03634982
What this trial is testing

Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors

Who this might be right for
Solid Tumors
Revolution Medicines, Inc. 133
Testing effectiveness (Phase 2)Active Not RecruitingNCT05094336
What this trial is testing

Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)

Who this might be right for
Advanced MTAP-null Solid Tumors
Amgen 329
Testing effectiveness (Phase 2)UnknownNCT06047860
What this trial is testing

A Clinical Study of Recombinant Human Vascular Endothelial Inhibitor in Combination With PRaG for Advanced Refractory Non-small Cell Lung Cancer

Who this might be right for
Advanced Solid TumorRefractory Tumor
Second Affiliated Hospital of Soochow University 30
Testing effectiveness (Phase 2)Study completedNCT00540982
What this trial is testing

Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction

Who this might be right for
Lung CancerUnspecified Adult Solid Tumor, Protocol Specific
City of Hope Medical Center 47
Early research (Phase 1)Looking for participantsNCT07232420
What this trial is testing

BL-M24D1 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Other Solid Tumors

Who this might be right for
Non Small Cell Lung CancerSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 33
Early research (Phase 1)Looking for participantsNCT07164313
What this trial is testing

ZW251 in Participants With Advanced Solid Tumors

Who this might be right for
Hepatocellular CarcinomaSquamous Cell Non-Small Cell Lung CancerGerm Cell Tumor
Zymeworks BC Inc. 100
Testing effectiveness (Phase 2)Study completedNCT00940225
What this trial is testing

Study of Cabozantinib (XL184) in Adults With Advanced Malignancies

Who this might be right for
Solid TumorsCancer
Exelixis 730
Early research (Phase 1)UnknownNCT04432857
What this trial is testing

AN0025 and Pembrolizumab Combination in Advanced Solid Tumors

Who this might be right for
Triple-negative Breast CancerNSCLC, Squamous or Non-SquamousUrothelial Carcinoma of the Bladder+2 more
Adlai Nortye Biopharma Co., Ltd. 63
Early research (Phase 1)Not Yet RecruitingNCT07699757
What this trial is testing

HSK41959 With Standard Therapy in Solid Tumors With MTAP Deletion

Who this might be right for
Non-Small Cell Lung CancerPancreatic Ductal Adenocarcinoma (mPDAC)Advanced Solid Tumors
Haisco Pharmaceutical Group Co., Ltd. 258
Testing effectiveness (Phase 2)Study completedNCT04332653
What this trial is testing

NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

Who this might be right for
Any Advanced Solid TumorsTriple Negative Breast CancerNon Small Cell Lung Cancer+4 more
NeoImmuneTech 215
Early research (Phase 1)Ended earlyNCT00585845
What this trial is testing

Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment

Who this might be right for
Malignant Epithelial MesotheliomaAdenocarcinoma of the PancreasCarcinoma, Non-Small-Cell Lung+1 more
Anza Therapeutics, Inc. 17
Next Page